Prescription Drug Information: Neo-Synephrine Hydrochloride

NEO-SYNEPHRINE HYDROCHLORIDE- phenylephrine hydrochloride injection, solution
Hospira, Inc.

PRINCIPAL DISPLAY PANEL — 1 mL Ampule Label

1 mL
NDC 0409-1800-01

Neo-Synephrine®
HCl

Rx only

phenylephrine HCl
injection, USP

10 mg/mL

1% Solution
Hospira, Inc. Lake Forest, IL 60045 USA

RL-1423 (11/05)

PRINCIPAL DISPLAY PANEL -- 1 mL Ampule Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 1 mL Ampule Cello Pack Label

1 mL (10 mg)
Single-dose
5 Ampuls
NDC 0409-1800-01

Neo-Synephrine® HCl
phenylephrine hydrochloride injection, USP
1% Sterile Aqueous Injection

FOR PARENTERAL USE
Rx only

PROTECT FROM LIGHT.

Each mL contains 10 mg NEO-SYNEPHRINE hydrochloride,
brand of phenylephrine hydrochloride, 3.5 mg sodium
chloride, 4 mg sodium citrate, 1 mg citric acid monohydrate,
and not more than 2 mg sodium metabisulfite as preservative.
For usual dosage and route of administration, see package
insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.]
WARNING: CONTAINS SULFITES.

Printed in USA
Hospira, Inc., Lake Forest, IL 60045 USA Hospira

RL-2067 (3/07)

PRINCIPAL DISPLAY PANEL -- 1 mL Ampule Cello Pack Label
(click image for full-size original)
NEO-SYNEPHRINE HYDROCHLORIDE phenylephrine hydrochloride injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:0409-1800
Route of Administration SUBCUTANEOUS, INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE) PHENYLEPHRINE HYDROCHLORIDE 10 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 3.5 mg in 1 mL
SODIUM CITRATE, UNSPECIFIED FORM 4 mg in 1 mL
CITRIC ACID MONOHYDRATE 1 mg in 1 mL
SODIUM METABISULFITE
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:0409-1800-01 5 AMPULE in 1 CELLO PACK contains a AMPULE
1 1 mL in 1 AMPULE This package is contained within the CELLO PACK (0409-1800-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
EXPORT ONLY 03/14/2006
Labeler — Hospira, Inc. (141588017)
Establishment
Name Address ID/FEI Operations
Hospira, Inc. 093132819 ANALYSIS (0409-1800), LABEL (0409-1800), MANUFACTURE (0409-1800), PACK (0409-1800)

Revised: 01/2021 Hospira, Inc.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

https://rxdruglabels.com/lib/rx/rx-meds/neo-synephrine-hydrochloride/

Clinical Trials

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2022. All Rights Reserved.